Travel: Expert discusses vaccines and Covid tests When you subscribe we will use the information you provide to send you…
Home »
Moderna COVID-19 vaccine trial in kids ages 12 to 17 hits full enrollment
New coronavirus variant may weaken effectiveness of vaccines Fox News medical contributor Dr. Marc Siegel details threat on ‘America’s Newsroom’…
Vaccine side effects: How the body responds and why being ill after a jab ‘is good’
For a fraction of people, getting these first COVID-19 vaccines could be unpleasant—more than the usual unpleasantness of getting a…
Vaccine trial participants who received placebo now hop the line for the real thing from Pfizer, Moderna
Good news for tens of thousands of volunteers in the COVID-19 vaccine trials: Many of those who received a placebo…
Moderna COVID-19 vaccine protection may last years, company claims
Moderna CEO Stéphane Bancel said the company’s COVID-19 vaccine may prevent infection for years, CBS News reported Thursday. While speaking…
Oregon health care worker hospitalized after allergic reaction to Moderna vaccine
COVID-19 vaccine distribution has been ‘extremely sluggish’: Dr. Nicole Saphier CDC data shows only 2.8 million people have been vaccinated…
Modern vaccine approved: Has UK ordered the Moderna vaccine and when will Britain get it?
Vaccine: Moderna trial volunteer discusses response on GMB The Modern vaccine has been approved by the US Food and Drug…
Moderna vaccine approval: Has the Moderna vaccine been approved in the UK?
Vaccine: Sharma grilled by Dan Walker over supply from Belgium Coronavirus vaccination is well underway in the UK, where health…
Moderna Announces Primary Efficacy Analysis in Phase 3 COVE Study for Its COVID-19 Vaccine Candidate and Filing Today with U.S. FDA for Emergency Use Authorization
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Nov. 30, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a…